Chugai in-licenses GLP-1/GIP receptor agonist CT-388 | The Pharmaletter

Retrieved on: 2025-10-13 15:02:03

Tags for this article:

Click the tags to see associated articles and topics

Chugai in-licenses GLP-1/GIP receptor agonist CT-388 | The Pharmaletter. View article details on hiswai:

Excerpt

Japanese drugmaker Chugai Pharmaceutical has concluded a license agreement with Roche for CT-388, a long-acting GLP-1/GIP receptor agonist, ...

Article found on: www.thepharmaletter.com